Tissue factor pathway inhibitor 2 (TFPI2) is a potential serum biomarker for clear cell renal carcinoma

Abstract Renal and ovarian clear cell carcinoma (CCC) are both characterized by a clear cytoplasm and exhibit similar genomic alterations and clinical characteristics. We hypothesized that both CCCs may share clinical biomarker. Tissue factor pathway inhibitor 2 (TFPI2), a serine protease inhibitor,...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Hiroki Ito, Ryosuke Jikuya, Shohei Myoba, Tomoyuki Tatenuma, Go Noguchi, Daiki Ueno, Yusuke Ito, Mitsuru Komeya, Kentaro Muraoka, Masahiro Yao, Hisashi Hasumi, Noboru Nakaigawa, Kazuhide Makiyama
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Nature Portfolio 2024-11-01
Σειρά:	Scientific Reports
Θέματα:	Serine protease inhibitor Placental protein Biomarker Kidney cancer Clear cell carcinoma
Διαθέσιμο Online:	https://doi.org/10.1038/s41598-024-80248-x
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!